Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria

Clinical and Experimental Immunology

Volumn 167, Issue 1, 2012, Pages 129-136

  Santos, J C ^a   de Brito, C A ^a   Futata, E A ^a   Azor, M H ^a   Orii, N M ^a   Maruta, C W ^a   Rivitti, E A ^a   Duarte, A J S ^a   Sato, M N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemokines; Chronic idiopathic urticaria; Innate immunity; Monocytes

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYTOHEMAGGLUTININ; RANTES; STAPHYLOCOCCUS ENTEROTOXIN A; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; BASOPHIL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INNATE IMMUNITY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN TEST; UPREGULATION; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; BASOPHIL DEGRANULATION TEST; CHEMOKINE CCL2; CHEMOKINES; CHRONIC DISEASE; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOCYTES; PHYTOHEMAGGLUTININS; REAL-TIME POLYMERASE CHAIN REACTION; SKIN TESTS; TOLL-LIKE RECEPTOR 4; UP-REGULATION; URTICARIA; YOUNG ADULT;

EID: 82655181542     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04485.x     Document Type: Article

References (36)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105:664-72.
2. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599-604.
3. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009; 39:777-87.
4. Sabroe RA, Francis DM, Barr RM etal. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102 (Pt 1):651-8.
5. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140:446-52.
6. Guttman-Yassky E, Bergman R, Maor C, Mamorsky M, Pollack S, Shahar E. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol 2007; 21:35-9.
7. Kaplan A. Inflammation in chronic urticaria is not limited to the consequences of mast cell (or basophil) degranulation. Clin Exp Allergy 2010; 40:834-5.
8. Caproni M, Cardinali C, Giomi B etal. Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria. J Dermatol Sci 2004; 36:57-9.
9. Ciprandi G, De Amici M, Berardi L etal. Serum neopterin levels in spontaneous urticaria and atopic dermatitis. Clin Exp Dermatol 2011; 36:85-7.
10. Tedeschi A, Lorini M, Suli C, Asero R. Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol 2007; 32:568-70.
11. Dos Santos JC, Azor MH, Nojima VY etal. Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol 2008; 8:1433-40.
12. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001; 2:95-101.
13. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7.
14. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21.
15. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-9.
16. Gerszten RE, Garcia-Zepeda EA, Lim YC etal. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999; 398:718-23.
17. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996; 156:2095-103.
18. Fulkerson PC, Zhu H, Williams DA, Zimmermann N, Rothenberg ME. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. Blood 2005; 106:436-43.
19. Bonecchi R, Bianchi G, Bordignon PP etal. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129-34.
20. Rotondi M, Rosati A, Buonamano A etal. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 2004; 4:1466-74.
21. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705.
22. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997; 158:4129-36.
23. Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003; 10:273-88.
24. Castellani ML, De Lutiis MA, Toniato E etal. Impact of RANTES, MCP-1 and IL-8 in mast cells. J Biol Regul Homeost Agents 2010; 24:1-6.
25. Gros E, Bussmann C, Bieber T, Förster I, Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124:753-60. e1.
26. Homey B, Meller S. Chemokines and other mediators as therapeutic targets in psoriasis vulgaris. Clin Dermatol 2008; 26:539-45.
27. Meller S, Gilliet M, Homey B. Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol 2009; 129:315-19.
28. Lourenço FD, Azor MH, Santos JC etal. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 2008; 158:979-86.
29. Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 2005; 35:456-60.
30. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25:386-401.
31. Futata E, Azor M, Dos Santos J etal. Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. Br J Dermatol 2011; 164:1271-9.
32. O'Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008; 409:635-49.
33. Puccetti A, Bason C, Simeoni S etal. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005; 35:1599-607.
34. Weber C, Belge KU, von Hundelshausen P etal. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000; 67:699-704.
35. Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 1990; 346:471-3.
36. Takahashi HK, Morichika T, Iwagaki H etal. Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin Immunol 2003; 108:274-81.